Home Bistro Announces 51% Increase In Repeat Customers And Offer Closing
Two big updates from the team at Home Bistro…
Two big updates from the team at Home Bistro…
Due to high demand, the Kleiner Device Labs offering is now oversubscribed.
Here’s a list of the most common questions investors have asked about the Home Bistro offering…
Here’s a list of the most common questions investors have asked about the Kleiner Device Labs offering…
Here’s a list of the most common questions investors have asked about the Sky Quarry offering…
Home Bistro has added another celebrity chef to its team. More dessert menu options are on the way.
Another announcement of record-breaking earnings from Home Bistro and more…
Earlier this week, we had the chance to interview Mike Hughes – Chief Commercial Officer at Kleiner Device Labs (KDL) – and had the chance to dive into several different topics about the company and opportunity.
A couple well-known media outlets featured Kleiner this past week.
The New York Post has recognized Home Bistro as a top at-home meal delivery company.
Two big updates from the team at Home Bistro…
Due to high demand, the Kleiner Device Labs offering is now oversubscribed.
Here’s a list of the most common questions investors have asked about the Home Bistro offering…
Here’s a list of the most common questions investors have asked about the Kleiner Device Labs offering…
Here’s a list of the most common questions investors have asked about the Sky Quarry offering…
Home Bistro has added another celebrity chef to its team. More dessert menu options are on the way.
Another announcement of record-breaking earnings from Home Bistro and more…
Earlier this week, we had the chance to interview Mike Hughes – Chief Commercial Officer at Kleiner Device Labs (KDL) – and had the chance to dive into several different topics about the company and opportunity.
A couple well-known media outlets featured Kleiner this past week.
The New York Post has recognized Home Bistro as a top at-home meal delivery company.
By submitting your email address you will receive access to this report and a free subscription to Equifund’s private investment newsletter. You can unsubscribe at any time and read more about our privacy policy here.
First-to-market remote patient care and telehealth platform that offers daily monitoring of qualified Medicare patients at no out-of-pocket cost.
Potential path to becoming a $1 billion company at current public market multiples.
Skyrocketing virtual medicine adoption rates -- especially among seniors -- thanks to COVID-19.
The next 8 slides will allow us to process your investment. Note that these next steps are a legal requirement – Thank you for your patience and financial support of this investment opportunity. Jordan Gillissie – CEO
Before we execute the investment, it’s important for us to make sure you’re comfortable and knowledgeable in early stage investing. We want to make sure that you:
We are currently upgrading our system. If you click submit and the process does not continue in a few seconds, please refresh this page manually, and click Invest Now again and you should be moved on to the next step.
Please wait a few minutes while we create your account. An email will be sent to you shortly to confirm your admittance. Should the email be delivered to your spam or promotions folder, we recommend you move it to your inbox and mark Equifund as a safe sender.
If you have not received the email in 5 minutes, please click here to have it resent.
Questions? Our customer service team is always here to help – 1-866-338-3004
Thank you for your investment in Home Bistro! To view the status of your investment, click the button below to navigate to your Dashboard.